Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| SK-BR-3 | 0 | uM | 9 | 5000.00 | 3570.27 | 6521.00 | 6344.00 | 1.0279 | 1.0675 | |
| SK-BR-3 | Linsitinib | 1 | uM | 9 | 5000.00 | 3570.27 | 6089.00 | 6344.00 | 0.9598 | 0.9035 |
| SK-BR-3 | Erlotinib | 0.031623 | uM | 9 | 5000.00 | 3570.27 | 6635.00 | 6344.00 | 1.0459 | 1.1111 |
| SK-BR-3 | Lapatinib | 0.31623 | uM | 9 | 5000.00 | 3570.27 | 3339.00 | 6344.00 | 0.5263 | -0.0776 |
| SK-BR-3 | 17-AAG | 0.0001 | uM | 9 | 5000.00 | 3570.27 | 6633.00 | 6344.00 | 1.0456 | 1.1104 |
| SK-BR-3 | 0 | uM | 9 | 5000.00 | 3570.27 | 6515.00 | 6344.00 | 1.0270 | 1.0652 | |
| SK-BR-3 | 17-AAG | 0.000302 | uM | 9 | 5000.00 | 3570.27 | 6426.00 | 6344.00 | 1.0129 | 1.0312 |
| SK-BR-3 | Erlotinib | 10 | uM | 9 | 5000.00 | 3570.27 | 3826.00 | 6344.00 | 0.6031 | 0.0870 |
| SK-BR-3 | 17-AAG | 0.001 | uM | 9 | 5000.00 | 3570.27 | 6429.00 | 6344.00 | 1.0134 | 1.0324 |
| SK-BR-3 | Lapatinib | 10 | uM | 9 | 5000.00 | 3570.27 | 3000.00 | 6344.00 | 0.4729 | -0.1893 |
| SK-BR-3 | 0 | uM | 9 | 5000.00 | 3570.27 | 6547.00 | 6344.00 | 1.0320 | 1.0774 | |
| SK-BR-3 | 0 | uM | 9 | 5000.00 | 3570.27 | 6295.00 | 6344.00 | 0.9923 | 0.9814 | |
| SK-BR-3 | 17-AAG | 0.000066069 | uM | 9 | 5000.00 | 3570.27 | 6417.00 | 6344.00 | 1.0115 | 1.0278 |
| SK-BR-3 | 0 | uM | 9 | 5000.00 | 3570.27 | 6312.00 | 6344.00 | 0.9950 | 0.9878 | |
| SK-BR-3 | 0 | uM | 9 | 5000.00 | 3570.27 | 5659.00 | 6344.00 | 0.8920 | 0.7426 | |
| SK-BR-3 | Erlotinib | 0.01 | uM | 9 | 5000.00 | 3570.27 | 5950.00 | 6344.00 | 0.9379 | 0.8512 |
| SK-BR-3 | Erlotinib | 3.1623 | uM | 9 | 5000.00 | 3570.27 | 5331.00 | 6344.00 | 0.8403 | 0.6216 |
| SK-BR-3 | 17-AAG | 0.31623 | uM | 9 | 5000.00 | 3570.27 | 2837.00 | 6344.00 | 0.4472 | -0.2421 |
| SK-BR-3 | Linsitinib | 19.9526 | uM | 9 | 5000.00 | 3570.27 | 4477.00 | 6344.00 | 0.7057 | 0.3137 |
| SK-BR-3 | Linsitinib | 0.01 | uM | 9 | 5000.00 | 3570.27 | 6494.00 | 6344.00 | 1.0236 | 1.0572 |
| SK-BR-3 | Linsitinib | 0.031623 | uM | 9 | 5000.00 | 3570.27 | 6459.00 | 6344.00 | 1.0181 | 1.0438 |
| SK-BR-3 | Lapatinib | 0.01 | uM | 9 | 5000.00 | 3570.27 | 5578.00 | 6344.00 | 0.8793 | 0.7126 |
| SK-BR-3 | 17-AAG | 0.031623 | uM | 9 | 5000.00 | 3570.27 | 4066.00 | 6344.00 | 0.6409 | 0.1697 |
| SK-BR-3 | Lapatinib | 0.1 | uM | 9 | 5000.00 | 3570.27 | 3738.00 | 6344.00 | 0.5892 | 0.0569 |
| SK-BR-3 | Erlotinib | 0.31623 | uM | 9 | 5000.00 | 3570.27 | 6725.00 | 6344.00 | 1.0601 | 1.1457 |